Latest News, Press Releases & Events

Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference

4 Posters detail SPX-101’s unique mechanism and potential to provide clinically meaningful benefit for all people with cystic fibrosis DURHAM, N.C., Nov. 1, 2017 /PRNewswire/ — Spyryx Biosciences, Inc., will share positive data this week highlighting additional insights into the mechanism of action and pharmacological importance of SPX-101, the Company’s pipeline therapeutic treatment for cystic fibrosis […]

Continue Reading